MGLN
Magellan Health Inc
Price:  
94.99 
USD
Volume:  
215,822.00
United States | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MGLN EV/EBITDA

-7.3%
Upside

As of 2024-03-03, the EV/EBITDA ratio of Magellan Health Inc (MGLN) is 12.62. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MGLN's latest enterprise value is 1,865.16 mil USD. MGLN's TTM EBITDA according to its financial statements is 147.79 mil USD. Dividing these 2 quantities gives us the above MGLN EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 10.5x - 12.1x 11.3x
Forward P/E multiples 11.2x - 12.4x 11.8x
Fair Price 83.12 - 92.17 88.08
Upside -12.5% - -3.0% -7.3%
94.99 USD
Stock Price
88.08 USD
Fair Price

MGLN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA